miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s171043
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Informa UK Limited